Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions – VISION Network, September 2023-February 2024
Authors: Fireman, Bruce; Goddard, Kristin S; Hansen, John; Klein, Nicola P; Zerbo, Ousseny | Mmwr. Morbidity And Mortality Weekly Report | March 28, 2024 | PubMed abstract
